Hepatocellular carcinoma - Quiz
A) Cystic and solid B) Encapsulated and diffused C) Fibrous and vascular D) Nodular and infiltrative
A) Red B) Yellow C) Blue D) Green
A) Exclusively solitary B) Poorly circumscribed and infiltrative C) Well circumscribed but not encapsulated D) Completely encapsulated
A) Pancreatic duct B) Portal veins C) Gallbladder D) Bile ducts
A) Two B) Five C) Four D) Six
A) Papillary B) Squamous C) Fibrolamellar D) Small cell
A) Bile duct cells B) Kupffer cells C) Endothelial cells D) Hepatocytes
A) Trabeculae, cords, and nests B) Papillae and follicles C) Sheets and clusters D) Acini and tubules
A) Bile accumulation B) Poor vascularization C) High lipid content D) Rapid cell division
A) Cholangiocarcinoma-like carcinoma B) Lymphoepithelioma-like hepatocellular carcinoma C) Sarcomatoid hepatocellular carcinoma D) Hepatoblastoma-like carcinoma
A) Cuboidal, organized, and encapsulated B) Uniform, cohesive, and small C) Columnar, glandular, and well-defined D) Discohesive, pleomorphic, anaplastic, and giant
A) Calcified B) Fibrotic C) Abundant D) Scant
A) After chemotherapy treatment B) In the early stages of development C) When the tumor is encapsulated D) As a complication of cirrhosis
A) Fatty cell B) Spindle cell C) Large cell D) Clear cell
A) Solitary nodule B) Encapsulated C) Well circumscribed D) Poorly circumscribed
A) X-ray B) Ultrasound C) MRI D) CT scan
A) Five B) Three C) Four D) Two
A) 81% B) 68% C) 85% D) 90%
A) Heterogeneous pattern B) High-intensity pattern C) Low-intensity pattern D) Iso-intense pattern
A) Low-intensity pattern B) Iso-intense pattern C) High-intensity pattern D) Variable intensity pattern
A) HCC-RADS B) LI-RADS C) LI-SCORE D) LIVER-CAT
A) It decreases B) It increases C) It remains the same D) It becomes unreliable
A) Patients with liver trauma B) Patients with fatty liver disease C) Pediatric patients D) Cirrhotic patients
A) 4 B) 5 C) 6 D) 3
A) No, if imaging criteria are met B) Only in late stages C) Only for small lesions D) Yes, always
A) 85% B) 90% C) 93% D) 68%
A) 50% B) 5% C) 35% D) 18%
A) Elderly individuals B) Females C) Children D) Males
A) Hemochromatosis B) Alcohol use C) NASH D) Hepatitis B
A) Hepatitis A B) Hepatitis D C) Hepatitis C D) Hepatitis B
A) 10% B) 80% C) 25% D) 50%
A) Hepatitis B B) Hepatitis E C) Hepatitis C D) Hepatitis A
A) Aflatoxin B) Mercury C) Lead D) Arsenic
A) Diabetes B) Hepatitis C C) Hemochromatosis D) Alcohol use disorder
A) Turner syndrome B) Alpha 1-antitrypsin deficiency C) Cystic fibrosis D) Down syndrome
A) Fifth B) Second C) Third D) First
A) High levels of iron in blood products B) Side effects of blood clotting medication C) Genetic predisposition to liver tumors D) Coincident chronic viral hepatitis infection
A) Beta-catenin activation mutation B) Alpha-fetoprotein dominant C) Hepatocyte-only adenoma D) Fibrolamellar variant
A) Blood glucose stability B) Type of carbohydrate consumption C) Physical activity level D) Circulating insulin concentration
A) Exclusive use of anabolic steroids B) Chronic high blood sugar C) High insulin output D) Tight insulin control
A) Hypertension B) Metabolic syndrome C) Chronic kidney disease D) Type 1 diabetes
A) Increased oxygen uptake or reduced liver size B) Higher replication rate or avoiding apoptosis C) High glucose consumption or reduced bile flow D) Viral integration or bile salt accumulation
A) By causing immune cells to attack liver cells B) By directly converting benign adenomas C) By blocking the bile salt export pump D) By increasing insulin production in the liver
A) Insulin-like growth factors B) Steroid hormones C) Bile salts D) Free radicals
A) 47–60% B) 70–85% C) 30–40% D) 10–20%
A) Increased apoptotic rate B) Reduced bile salt export C) Decreased cell division D) Constitutively active telomerase
A) 10% B) 30% C) 5% D) 60%
A) Wnt B) TP53 C) ABCB11 D) TERT
A) AXIN1 B) TP53 C) ABCB11 D) CTNNB1
A) Blood testing B) Genetic screening C) Biopsy D) Physical examination
A) CTNNB1 B) ARID1A C) ABCB11 D) AXIN1
A) Every eighteen months B) Every three months C) Every twelve months D) Every six months
A) 80–94% B) 41–65% C) 99% D) 31%
A) 99% B) 31% C) 41–65% D) 80–94%
A) 41% B) 60% C) 79% D) 97%
A) MRI B) CT scan C) PET scan D) Ultrasound
A) 31% B) 79% C) 97% D) 60%
A) Intravenous contrast in multiple phases B) Oral contrast agents C) Sedation-free imaging D) Low-dose radiation scanning
A) Diagnosis occurs at an advanced stage B) Poor patient compliance C) Lack of available treatment D) Rapid resistance to chemotherapy
A) Liver transaminases B) C-reactive protein C) Alkaline phosphatase D) Des-gamma carboxyprothrombin
A) It is standard of care worldwide B) It is not recommended under any circumstances C) There is some controversy surrounding whether surveillance reduces mortality D) It is definitively proven to reduce mortality |
Created with That Quiz —
where test making and test taking are made easy for math and other subject areas.